HighTower Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$73.1M Buy
857,336
+40,604
+5% +$3.62M 0.08% 258
2025
Q4
$64.5M Sell
816,732
-33,957
-4% -$2.66M 0.07% 276
2025
Q3
$68M Sell
850,689
-49,628
-6% -$4.23M 0.08% 260
2025
Q2
$81.8M Sell
900,317
-9,433
-1% -$861K 0.1% 211
2025
Q1
$85.2M Sell
909,750
-24,078
-3% -$2.16M 0.12% 190
2024
Q4
$84.9M Sell
933,828
-36,212
-4% -$3.46M 0.12% 183
2024
Q3
$101M Buy
970,040
+44,482
+5% +$4.53M 0.14% 156
2024
Q2
$89.8M Sell
925,558
-15,422
-2% -$1.42M 0.14% 162
2024
Q1
$84.8M Sell
940,980
-46,265
-5% -$3.92M 0.14% 171
2023
Q4
$78.7M Buy
987,245
+16,648
+2% +$1.25M 0.13% 169
2023
Q3
$69M Sell
970,597
-4,017
-0.4% -$300K 0.13% 165
2023
Q2
$75.1M Buy
974,614
+18,448
+2% +$1.43M 0.15% 148
2023
Q1
$71.9M Sell
956,166
-30,743
-3% -$2.29M 0.16% 153
2022
Q4
$77.8M Buy
986,909
+46,189
+5% +$3.46M 0.18% 130
2022
Q3
$66.1M Sell
940,720
-22,878
-2% -$1.79M 0.18% 128
2022
Q2
$77.2M Buy
963,598
+12,550
+1% +$981K 0.2% 110
2022
Q1
$72.1M Buy
951,048
+1,999
+0.2% +$158K 0.16% 134
2021
Q4
$81M Buy
949,049
+271,174
+40% +$21.2M 0.18% 126
2021
Q3
$51.2M Buy
677,875
+310,455
+84% +$24.7M 0.14% 155
2021
Q2
$29.9M Buy
367,420
+449
+0.1% +$36.7K 0.09% 239
2021
Q1
$28.9M Sell
366,971
-21,753
-6% -$1.71M 0.09% 230
2020
Q4
$33.2M Buy
388,724
+13,702
+4% +$1.13M 0.14% 149
2020
Q3
$28.9M Buy
375,022
+3,663
+1% +$279K 0.14% 156
2020
Q2
$27.2M Buy
371,359
+17,978
+5% +$1.28M 0.15% 149
2020
Q1
$23.5M Sell
353,381
-15,960
-4% -$1.13M 0.15% 148
2019
Q4
$25.4M Sell
369,341
-1,296
-0.3% -$88.4K 0.15% 153
2019
Q3
$27.2M Buy
370,637
+3,412
+0.9% +$248K 0.15% 146
2019
Q2
$26.3M Buy
367,225
+921
+0.3% +$65.4K 0.16% 139
2019
Q1
$25.1M Sell
366,304
-25,432
-6% -$1.64M 0.17% 129
2018
Q4
$23.3M Buy
391,736
+65,395
+20% +$4.09M 0.18% 119
2018
Q3
$21.8M Sell
326,341
-17,839
-5% -$1.19M 0.16% 139
2018
Q2
$22.3M Sell
344,180
-3,613
-1% -$236K 0.17% 122
2018
Q1
$24.9M Sell
347,793
-2,417
-0.7% -$174K 0.21% 106
2017
Q4
$26.4M Buy
350,210
+3,940
+1% +$288K 0.22% 105
2017
Q3
$25.2M Sell
346,270
-480
-0.1% -$34.6K 0.22% 98
2017
Q2
$25.7M Buy
346,750
+3,293
+1% +$244K 0.23% 88
2017
Q1
$25.1M Sell
343,457
-11,948
-3% -$836K 0.24% 83
2016
Q4
$23.3M Sell
355,405
-5,140
-1% -$352K 0.25% 79
2016
Q3
$26.7M Buy
360,545
+7,302
+2% +$540K 0.31% 66
2016
Q2
$25.9M Buy
353,243
+3,062
+0.9% +$218K 0.33% 65
2016
Q1
$24.7M Sell
350,181
-8,352
-2% -$556K 0.08% 87
2015
Q4
$23.9M Sell
358,533
-9,161
-2% -$609K 0.28% 74
2015
Q3
$23.4M Buy
367,694
+155,579
+73% +$10.2M 0.31% 70
2015
Q2
$13.9M Sell
212,115
-809
-0.4% -$54.9K 0.22% 99
2015
Q1
$14.8M Sell
212,924
-136,988
-39% -$9.47M 0.22% 97
2014
Q4
$24.2M Buy
349,912
+4,112
+1% +$278K 0.37% 54
2014
Q3
$22.6M Sell
345,800
-1,192
-0.3% -$78.6K 0.38% 47
2014
Q2
$23.7M Buy
346,992
+2,534
+0.7% +$170K 0.41% 45
2014
Q1
$22.3M Buy
344,458
+841
+0.2% +$53K 0.44% 43
2013
Q4
$22.4M Buy
343,617
+12,913
+4% +$826K 0.46% 40
2013
Q3
$19.6M Sell
330,704
-1,868
-0.6% -$111K 0.49% 39
2013
Q2
$19.1M Buy
+332,572
New +$19.7M 0.52% 37

Other funds holding CL

HighTower Advisors's CL Position: Q1 2026 in Review

HighTower Advisors increased its Colgate-Palmolive (CL) stake by 5% in Q1 2026, buying an estimated $3.62M and bringing the position to 857,336 shares worth $73.1M. The position accounts for 0.08% of the portfolio, ranked #258.

HighTower Advisors first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $101M in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • HighTower Advisors held 857,336 shares of Colgate-Palmolive worth $73.1M as of Q1 2026.
  • HighTower Advisors bought 40,604 Colgate-Palmolive shares in Q1 2026, an estimated $3.62M.
  • Colgate-Palmolive made up 0.08% of HighTower Advisors's portfolio in Q1 2026, its #258 holding.
  • HighTower Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • HighTower Advisors's Colgate-Palmolive position peaked at $101M in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.